Today's News |
'Fantastic' Results From Lupus-Drug Trials Add Nearly $1 Billion in Day to Vancouver Island Firm
Friday, December 6, 2019Company Profile | Follow Company
Victoria, BC, December 6, 2019--The value of shares in a Saanich-based pharmaceutical company (Aurinia Pharmaceuticals) soared Thursday after the firm announced what it called "fantastic" results from the third phase of clinical trials for a drug used to treat a kidney inflammation caused by the autoimmune disease lupus.
|